Cargando…
RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma
INTRODUCTION: RBM10 is one of the frequently mutated genes in lung adenocarcinoma (LUAD). Previous studies have confirmed that RBM10 could suppress the disease progression and cell proliferation in LUAD, but its loss-of-function mutations are more frequent in early-stage disease and decrease with th...
Autores principales: | Liu, Bing, Wang, Yaqi, Wang, Han, Li, Zhongwu, Yang, Lujing, Yan, Shi, Yang, Xin, Ma, Yuanyuan, Gao, Xuan, Guan, Yanfang, Yi, Xin, Xia, Xuefeng, Li, Jingjing, Wu, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336464/ https://www.ncbi.nlm.nih.gov/pubmed/34367963 http://dx.doi.org/10.3389/fonc.2021.677826 |
Ejemplares similares
-
RBM10 Regulates Tumor Apoptosis, Proliferation, and Metastasis
por: Cao, Yingshu, et al.
Publicado: (2021) -
Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer
por: Lian, Shenyi, et al.
Publicado: (2021) -
Functional role of RBM10 in lung adenocarcinoma proliferation
por: Sun, Xiuna, et al.
Publicado: (2018) -
RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway
por: Jin, Xin, et al.
Publicado: (2019) -
Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay
por: Sun, Yue, et al.
Publicado: (2017)